Originator Organization Crossbow Therapeutics, Inc.Startup |
Active Organization Crossbow Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | Crossbow Therapeutics, Inc.Startup | 16 Sep 2024 |